Genomcore Wins PRECISEU Award for Innovation in Personalized Medicine
Genomcore has received the Best Practice Recognition award in the Impact category for the European project PRECISEU, which promotes personalized medicine in Europe. The award was presented at Life Sciences Baltics 2025 in Vilnius, Lithuania.
Genomcore, the leading company in biomedical data management, has been honored with the Best Practice Recognition award in the Impact category. This accolade was granted by the European project PRECISEU, which aims to map personalized medicine across Europe. The ceremony took place on September 18, 2025, during the Life Sciences Baltics 2025 conference in Vilnius, Lithuania, where the company's co-founder, Miquel Àngel Bru, accepted the award.
The jury highlighted the sustainability, harmonization, and quality control of the data incorporated into the Genomcore BIMS system. Bru noted that the award validates the company's focus on bringing personalized medicine in the real world and in the forefront of healthcare, solidifying its position as a key player in the European ecosystem.
The award specifically recognizes Genomcore's work on the DIPCAN project (Digitalization and Integral Management of Personalized Medicine in Cancer), for which a consortium of 7 leading organizations was created: MC Anderson Cancer Center, Eurofins, Genomcore, Pangaea Oncology, Atrys, Quibim, and Artelnics. The main challenge was to integrate clinical, genomic, anatomical pathology, and radiomic data to select the most appropriate cancer treatment, using advanced artificial intelligence models.
DIPCAN harmonized over 60 TB of data from more than 130 Spanish hospitals, integrating over 29 types of data sources. It was funded by the Ministry of Economic Affairs and Digital Transformation, through the Secretary of State for Digitalization and Artificial Intelligence. The project also received co-funding from the European Union through the Recovery and Resilience Mechanism.
Genomcore has recently led key projects in the field of genetics and public health, such as SiGenEs (the Spanish National Health System's national genomic information exchange network), OMIQ-HES (Catalonia's Public Health System), Osagen (the Basque Country's Public Health System), and Medigenomics (the Community of Madrid).